Myofascial Pain Syndrome vs Fibromyalgia: Understanding the Key Differences

If you’re living with widespread pain and struggling to get clear answers about what’s causing your symptoms, you’re not alone. Many people find themselves caught between different diagnoses, wondering whether they have myofascial pain syndrome, fibromyalgia, or something else entirely. This confusion is completely understandable. These conditions share many similarities and can even occur together.

Another similarity: both conditions are frequently dismissed by clinicians, leaving patients to navigate their pain without adequate support for years¹. The good news is that medical understanding of both conditions has improved significantly, with clearer diagnostic criteria and evidence-based treatment approaches now available.

This article examines the current medical evidence on both conditions, helping you understand how they’re diagnosed, what treatments research shows may be helpful, and when individual responses might vary because what works for one person may not work for another.

Current Medical Understanding of These Conditions

Both myofascial pain syndrome and fibromyalgia are legitimate medical conditions that cause real, often debilitating pain. Research published in Clinical Rheumatology in 2023 shows that myofascial pain syndrome may affect up to 85% of adults at some point in their lives, while fibromyalgia affects approximately 2-4% of the population²^,³.

Myofascial pain syndrome involves trigger points, which are specific areas of muscle that become tight and painful, often causing pain that spreads to other areas, according to a review in Muscle and Nerve in 2025⁴. These trigger points can develop after muscle injury, repetitive strain, or periods of stress⁵.

Fibromyalgia is characterized by widespread pain throughout the body, along with fatigue, sleep problems, and cognitive difficulties often called “fibro fog”. While the root causes of fibromyalgia are still being researched, understanding fibromyalgia as a widespread pain condition helps explain why it affects multiple body systems and requires comprehensive treatment approaches. Current research suggests it involves changes in how your nervous system processes pain signals, a mechanism called central sensitization⁶.

While these conditions can occur separately, studies indicate they may also overlap in some individuals. A 2022 systematic review published in PLOS ONE found that, in some patients, regionally localized myofascial pain syndrome may appear to evolve into fibromyalgia as symptoms progress⁷.

Research-Based Diagnostic Approaches and Accuracy

The evolution of fibromyalgia diagnosis criteria reflects how medical understanding has improved, with the American College of Rheumatology updating its approach in 2010 and again in 2016 to reflect improved clinical knowledge⁸.

Current fibromyalgia diagnostic criteria achieve about 86% sensitivity and 90% specificity, meaning they correctly identify about 9 out of 10 people who have the condition, according to research published in Seminars in Arthritis and Rheumatism⁸. The diagnosis focuses on widespread pain in multiple body regions lasting at least three months, combined with other symptoms like fatigue and cognitive difficulties.

Myofascial pain syndrome diagnosis relies more on physical examination, particularly identifying trigger points that reproduce your specific pain pattern⁹. However, research published in the Journal of the Canadian Chiropractic Association in 2018 notes that diagnostic approaches for myofascial pain syndrome are less standardized than those for fibromyalgia¹⁰.

Individual variation in symptoms means your experience may not fit perfectly into diagnostic categories. This doesn’t make your pain less real or important. Working with healthcare providers familiar with these conditions is essential for accurate diagnosis, especially given the complexity involved¹¹.

If you’re experiencing widespread pain and wondering whether it might be fibromyalgia or myofascial pain syndrome, taking our comprehensive assessment can help you understand your symptoms better and prepare for productive conversations with healthcare providers.

Evidence for Treatment Effectiveness and Individual Variation

Research published in the Cochrane Database of Systematic Reviews in 2013 shows that treatment responses vary significantly between individuals for both conditions, with some people experiencing substantial improvement while others may need to try multiple approaches¹².

For Myofascial Pain Syndrome:

People with myofascial pain syndrome have several treatment options that can be used individually or together¹³:

Physical Treatments:

• Shock wave therapy that sends gentle energy waves to painful trigger points
• Physical therapy with stretching, massage, and special tape that supports muscles
• Heat treatments, light therapy, and magnetic therapy to reduce pain

Injection Options:

• Trigger point injections where your doctor injects numbing medicine (lidocaine) or anti-inflammatory medication directly into painful spots
• Botulinum toxin (botox) injections for severe cases
• Dry needling, where thin needles are placed in trigger points without medication

Needle Treatments:

• Acupuncture provides short-term pain relief³¹
• Specialized needle techniques with heat for stubborn cases

Medications Your Doctor May Suggest:

• Anti-inflammatory medicines like ibuprofen to reduce pain and swelling
• Antidepressants such as duloxetine or amitriptyline, which can help with chronic pain (even if you’re not depressed)³²
• Nerve pain medications like gabapentin or pregabalin
• Muscle relaxants like tizanidine when muscles are very tight

Advanced Procedures:

• Radiofrequency treatment that uses heat or electrical pulses to interrupt pain signals
• Nerve blocks guided by ultrasound or X-ray

For Fibromyalgia:

Clinically-recommended treatment approaches for fibromyalgia include a combination of treatments rather than relying on any single intervention. Research consistently shows that multimodal care addressing both the physical and psychological aspects of fibromyalgia produces the best outcomes for patients.

Behavioral therapy approaches demonstrate some of the strongest evidence for fibromyalgia management. A landmark 2024 study published in The Lancet found that 71% of people with fibromyalgia showed meaningful improvement using a digital acceptance and commitment therapy program³³. The study demonstrated significant improvements across multiple symptoms, including pain, fatigue, sleep problems, and depression, with no adverse effects reported. Current clinical guidelines recommend combining behavioral approaches with movement therapy and other treatments as part of a comprehensive care plan.

Research published in 2017 by leading European rheumatology experts found that movement therapy shows the strongest evidence for helping people with fibromyalgia¹⁷. The study, which appeared in the Annals of the Rheumatic Diseases, reviewed all available research on fibromyalgia treatments and concluded that while many approaches may provide some benefit, movement and activity programs have the most consistent support from high-quality studies.

Other options to treat fibromyalgia include three FDA-approved medications: pregabalin, duloxetine, and milnacipran, each working through different mechanisms to help manage pain and other symptoms¹⁵. Clinical trials show these medications help about 1 in 3 t people achieve meaningful pain relief, typically requiring 6-8 weeks to determine effectiveness, according to a study in Arthritis & Rheumatism published in 2007¹⁶.

Both fibromyalgia and myofascial pain syndrome can cause significant discomfort, and managing chronic pain requires understanding your individual response to different approaches, from movement therapy to pharmacological treatments.

Understanding the differences between these conditions is important because treatment approaches may vary. To explore treatment options that might be right for your specific situation, working with specialists who understand both conditions can make a significant difference.

Study Findings on Condition Overlap and Distinctions

Recent research helps clarify how these conditions relate to each other. A 2018 study published in the Journal of the Canadian Chiropractic Association found that while myofascial pain syndrome typically involves localized trigger points, fibromyalgia involves more widespread changes in pain processing throughout the nervous system¹⁸.

Key research-based distinctions include:

• Pain patterns: Myofascial pain often follows specific referral patterns from trigger points, while fibromyalgia pain tends to be more widespread and variable¹⁹
• Laboratory findings: Fibromyalgia typically shows normal inflammatory markers, while myofascial pain syndrome may involve localized tissue changes²⁰
• Response to pressure: People with fibromyalgia often show heightened sensitivity to pressure throughout the body, while myofascial pain focuses on specific trigger points, according to neurophysiology research¹⁸

While myofascial pain typically involves localized trigger points, fibromyalgia encompasses a broader range of symptoms including widespread pain, fatigue, sleep problems, and cognitive difficulties (also known as brain fog).

However, clinical studies consistently show that these conditions can coexist. Research indicates that some people develop fibromyalgia after experiencing chronic myofascial pain, suggesting these conditions may sometimes represent different stages of similar underlying processes²¹.

Your healthcare provider can help distinguish between these conditions based on your specific symptom pattern, particularly since individual experiences can vary significantly from textbook descriptions.

Clinical Research on Medical Recognition and Patient Experience

Unfortunately, research validates what many patients experience: both conditions are often dismissed or minimized by healthcare providers. A 2024 systematic review published in Medicine found that myofascial pain syndrome is “often dismissed by clinicians while patients remain in pain for years”²².

Studies published in Medical Education and Patient Care Research suggest this dismissal often occurs because:

• Many healthcare providers have limited experience with fibromyalgia, which can make it challenging to get an accurate diagnosis quickly. Research published in The Journal for Nurse Practitioners in 2025 shows it typically takes 2 to 6 years from first symptoms to receive a fibromyalgia diagnosis. A review published in the Journal of Education and Health Promotion in 2021 suggests that better training for doctors could help people get the care they need sooner²³
• Both conditions lack simple blood tests or imaging that show clear abnormalities, according to diagnostic research²⁴
• Symptoms can fluctuate, making diagnosis more challenging as noted in clinical assessment studies²⁵
• Some providers still may not recognize these as legitimate medical conditions, according to healthcare provider surveys, often due to gaps in medical education and recognition²⁶

Research published in Psychology & Health in 2025 found that people with fibromyalgia often see multiple healthcare providers before receiving appropriate care, with many reporting they felt dismissed or not believed²⁷.

Given that research validates how both conditions are often dismissed by healthcare providers, finding healthcare providers who understand these conditions and take your symptoms seriously is crucial for getting appropriate care.

Professional Medical Consultation and Diagnostic Protocols

Because fibromyalgia can be complex to diagnose and treat, working with a healthcare provider who understands the condition can make a meaningful difference in your care. Research published in Medicine in 2024 shows that doctors who specialize in fibromyalgia tend to be more familiar with current diagnostic guidelines and may be more likely to recognize fibromyalgia symptoms accurately²⁸. 

A study on patient preferences published in PLOS ONE in 2024 found many patients strongly prefer getting their diagnosis and ongoing care from specialists²⁹. Patients often report feeling more confident about their treatment plan and more understood when working with doctors who have experience treating fibromyalgia.

What to expect from quality medical evaluation:

• Comprehensive symptom history over several months
• Discussion of how symptoms affect your daily functioning
• Consideration of other conditions that might cause similar symptoms
• Development of an individualized treatment plan

Your medical team can help determine whether you have one condition, both, or something else entirely. Professional guidance is particularly important because treatment approaches may differ depending on your specific diagnosis.

In addition to professional myofascial-pain-syndrome-vs-fibromyalgiamedical care, connecting with others who understand these conditions can provide valuable insights and emotional support during your healthcare journey.

When to Seek Professional Medical Evaluation

Consider seeking medical evaluation if you experience:

• Persistent muscle pain lasting several months
• Widespread pain affecting multiple body areas
• Pain that interferes with sleep, work, or daily activities
• Symptoms that haven’t improved with rest or over-the-counter treatments
• Concerns about whether your symptoms might indicate fibromyalgia or myofascial pain syndrome

How Swing Care Can Help: Evidence-Based Comprehensive Care

At Swing Care, we understand the complexity of chronic pain conditions and the frustration of trying to get clear answers. Our fibromyalgia specialists are experienced in evaluating fibromyalgia, using current diagnostic criteria and evidence-based treatment approaches. We provide virtual consultations that make specialized care accessible, especially on days when your symptoms make travel difficult.

Early evaluation and appropriate treatment can make a significant difference in managing these conditions effectively. Remember that finding the right treatment approach often takes time and patience, and what works for one person may not work for another.

This information represents current medical evidence as of September 2025 and is intended for educational purposes only. Myofascial pain syndrome and fibromyalgia diagnosis and treatment decisions should be made collaboratively with qualified healthcare providers who can assess individual circumstances. Evidence quality and treatment responses vary significantly between individuals, as demonstrated in current clinical research. This content does not constitute medical advice, diagnoses, or treatment recommendations.

Sources

1. Darnall, B. D., Edwards, K. A., Courtney, R. E., Ziadni, M. S., Simons, L. E., & Harrison, L. E. (2023). Innovative treatment formats, technologies, and clinician trainings that improve access to behavioral pain treatment for youth and adults. Frontiers in Pain Research, 4, Article 1223172. https://doi.org/10.3389/fpain.2023.1223172
2. Fleckenstein, J., Zaps, D., Rüger, L. J., Lehmeyer, L., Freiberg, F., Lang, P. M., & Irnich, D. (2010). Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC musculoskeletal disorders, 11, 32. https://doi.org/10.1186/1471-2474-11-32
3. Rivera, F. A., Munipalli, B., Allman, M. E., Hodge, D. O., Wieczorek, M. A., Wang, B., Abril, A., Perlman, A., Knight, D., & Bruce, B. (2024). A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Frontiers in Medicine, 10, Article 1301944. https://doi.org/10.3389/fmed.2023.1301944
4. Steen, J. P., Jaiswal, K. S., & Kumbhare, D. (2025). Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment. Muscle & nerve, 71(5), 889–910. https://doi.org/10.1002/mus.28377
5. Gerwin RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Current Pain and Headache Reports. 2001;5(5):412-420. https://pubmed.ncbi.nlm.nih.gov/11560806/
6. Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114-129. https://pubmed.ncbi.nlm.nih.gov/27291641/
7. Plaut, S. (2022). Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle. PLOS ONE, 17(2), e0263087. https://doi.org/10.1371/journal.pone.0263087
8. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism. 2016;46(3):319-329. https://pubmed.ncbi.nlm.nih.gov/27916278/
9. Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. 2nd ed. Baltimore, MD: Williams & Wilkins; 1999.
10. Bourgaize, S., Newton, G., Kumbhare, D., & Srbely, J. (2018). A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management. Journal of the Canadian Chiropractic Association, 62(1), 26–41. https://pmc.ncbi.nlm.nih.gov/articles/PMC6160895/
11. Bean, D. J., Tuck, N. L., Magni, N., et al. (2025). The efficacy of an interdisciplinary pain management program for complex regional pain syndrome compared to low back pain and chronic widespread pain: An observational study. Pain Medicine, 26(4), 180–188. https://academic.oup.com/painmedicine/article/26/4/180/7922563
12. Bernardy K, Klose P, Busch AJ, et al. Cognitive behavioural therapies for fibromyalgia. Cochrane Database of Systematic Reviews. 2013;(9):CD009796. https://pubmed.ncbi.nlm.nih.gov/24018611/
13. Cao, Q. W., Peng, B. G., Wang, L., Huang, Y. Q., Jia, D. L., Jiang, H., Lv, Y., Liu, X. G., Liu, R. G., Li, Y., Song, T., Shen, W., Yu, L. Z., Zheng, Y. J., Liu, Y. Q., & Huang, D. (2021). Expert consensus on the diagnosis and treatment of myofascial pain syndrome. World Journal of Clinical Cases, 9(9), 2077–2089. https://doi.org/10.12998/wjcc.v9.i9.2077
14. Ram, P. R., Jeyaraman, M., Jeyaraman, N., Nallakumarasamy, A., Khanna, M., Gupta, A., & Yadav, S. (2023). Beyond the Pain: A Systematic Narrative Review of the Latest Advancements in Fibromyalgia Treatment. Cureus, 15(10), e48032. https://doi.org/10.7759/cureus.48032
15. Wang, Y., Li, L., Guo, J., & Wang, R. (2022). Pharmacological treatments of fibromyalgia in adults. Frontiers in Pharmacology, 13, 1017129. https://doi.org/10.3389/fphar.2022.1017129
16. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis & Rheumatism. 2007;56(4):1336-1344. https://pubmed.ncbi.nlm.nih.gov/17393438/
17. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases. 2017;76(2):318-328. https://pubmed.ncbi.nlm.nih.gov/27377815/
18. Bourgaize, S., Newton, G., Kumbhare, D., & Srbely, J. (2018). A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: Implications for differential diagnosis and management. Journal of the Canadian Chiropractic Association, 62(1), 26–41. https://pmc.ncbi.nlm.nih.gov/articles/PMC6160895/
19. Gerwin, R. D. (2018). Myofascial Pain. Seminars in Neurology, 38(5), 486–491. https://doi.org/10.1055/s-0038-1673674
20. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis & Rheumatism. 2003;48(5):1420-1429. https://pubmed.ncbi.nlm.nih.gov/12746916/
21. Leblebici, B., Pektaş, Z. O., Ortancil, O., Hürcan, E. C., Bagis, S., & Akman, M. N. (2007). Coexistence of fibromyalgia, temporomandibular disorder, and masticatory myofascial pain syndromes. Rheumatology international, 27(6), 541–544. https://doi.org/10.1007/s00296-006-0251-z
22. Antunes, M. D., Couto, L. A., Bertolini, S. M. M. G., Loures, F. C. N. R., Schmitt, A. C. B., & Marques, A. P. (2021). Effectiveness of interdisciplinary health education programs for individuals with fibromyalgia: A systematic review. Journal of Education and Health Promotion, 10, 64. https://doi.org/10.4103/jehp.jehp_592_20
23. Casseus, K., Cabahug, I. N. K., Owusu, B., Atraga, C. F., & Balthazar, M. S. (2025). Fibromyalgia and primary care providers’ plan of care. The Journal for Nurse Practitioners, 21(8), 105461. https://doi.org/10.1016/j.nurpra.2025.105461
24. Goldenberg DL. Diagnosis and differential diagnosis of fibromyalgia. American Journal of Medicine. 2009;122(12 Suppl):S14-21. https://pubmed.ncbi.nlm.nih.gov/19962492/
25. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis & Rheumatism. 1990;33(2):160-172. https://pubmed.ncbi.nlm.nih.gov/2306288/
26. Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Services Research. 2010;10:102. https://pubmed.ncbi.nlm.nih.gov/20420681/
27. Maher, C., & Gaffiero, D. (2025). Exploring the lived experiences of patients with fibromyalgia in the United Kingdom: a study of patient-general practitioner communication. Psychology & Health, 1–22. https://doi.org/10.1080/08870446.2025.2474013
28. Agarwal, A., Emary, P. C., Gallo, L., Oparin, Y., Shin, S. H., Fitzcharles, M. A., Adachi, J. D., Cooper, M. D., Craigie, S., Rai, A., Wang, L., Couban, R. J., & Busse, J. W. (2024). Physicians’ knowledge, attitudes, and practices regarding fibromyalgia: A systematic review and meta-analysis of cross-sectional studies. Medicine, 103(31), e39109. https://doi.org/10.1097/MD.0000000000039109
29. Norwood, P., Beasley, M., Stevens, M., Hollick, R., Macfarlane, G., McNamee, P., & PACFiND Study Investigators. (2024). Patient preferences for models of care for fibromyalgia: A discrete choice experiment. PLOS ONE, 19(6), e0305030. https://doi.org/10.1371/journal.pone.0305030
30. Steen, J. P., Jaiswal, K. S., & Kumbhare, D. (2025). Myofascial pain syndrome: An update on clinical characteristics, etiopathogenesis, diagnosis, and treatment. Muscle & Nerve, 71(5), 889–910. https://doi.org/10.1002/mus.28377
31. Xiong J, Zhou X, Luo X, Gong X, Jiang L, Luo Q, Zhang S, Jiang C, Pu T, Liu J, Zhang J, Li B, Chi H. Acupuncture therapy on myofascial pain syndrome: a systematic review and meta-analysis. Front Neurol. 2024 May; 15:1374542. https://pubmed.ncbi.nlm.nih.gov/38765261/
32. Cao, Q.-W., Peng, B.-G., Wang, L., Huang, Y.-Q., Jia, D.-L., Jiang, H., Lv, Y., Liu, X.-G., Liu, R.-G., Li, Y., Song, T., Shen, W., Yu, L.-Z., Zheng, Y.-J., Liu, Y.-Q., & Huang, D. (2021). Expert consensus on the diagnosis and treatment of myofascial pain syndrome. World Journal of Clinical Cases, 9(9), 2077–2098. https://doi.org/10.12998/wjcc.v9.i9.2077
33. Gendreau RM, Mease PJ, Chinn LW, et al. Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial. The Lancet. 2024;404(10449):205-216. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00909-7/fulltext